PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 141 filers reported holding PDL BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $485,000 | -81.5% | 196,783 | -76.3% | 0.00% | -83.3% |
| Q3 2020 | $2,615,000 | +27.3% | 829,880 | +17.5% | 0.01% | +20.0% |
| Q2 2020 | $2,054,000 | +7.3% | 706,384 | +4.0% | 0.01% | 0.0% |
| Q1 2020 | $1,915,000 | -41.3% | 679,430 | -32.5% | 0.01% | -16.7% |
| Q4 2019 | $3,263,000 | +61.9% | 1,005,962 | +7.9% | 0.01% | +50.0% |
| Q3 2019 | $2,015,000 | +48.1% | 932,384 | +114.9% | 0.00% | +33.3% |
| Q2 2019 | $1,361,000 | -27.4% | 433,856 | -14.0% | 0.00% | 0.0% |
| Q1 2019 | $1,875,000 | +8.7% | 504,191 | -15.9% | 0.00% | -25.0% |
| Q4 2018 | $1,725,000 | -14.1% | 599,850 | -21.7% | 0.00% | 0.0% |
| Q3 2018 | $2,007,000 | -27.5% | 765,632 | -35.6% | 0.00% | -33.3% |
| Q2 2018 | $2,767,000 | -58.1% | 1,188,121 | -47.2% | 0.01% | -45.5% |
| Q1 2018 | $6,611,000 | +13.1% | 2,248,464 | +11.2% | 0.01% | +10.0% |
| Q4 2017 | $5,845,000 | -15.4% | 2,022,766 | -0.7% | 0.01% | -16.7% |
| Q3 2017 | $6,908,000 | +43.4% | 2,037,666 | +4.5% | 0.01% | +33.3% |
| Q2 2017 | $4,816,000 | -2.9% | 1,949,778 | -10.8% | 0.01% | 0.0% |
| Q1 2017 | $4,961,000 | +20.9% | 2,185,731 | +12.9% | 0.01% | +12.5% |
| Q4 2016 | $4,104,000 | – | 1,936,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |